Clinical Testing of a Multi-Peptide Eye Serum for Reducing Wrinkles and Improving Skin Quality

A multi-peptide eye serum reduced wrinkle number, depth, and volume around the eyes while improving skin hydration and elasticity over 28 days in a small clinical study.

Li, Fengzhu et al.·Journal of cosmetic dermatology·2023·lowclinical trial
RPEP-07094Clinical triallow2023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
clinical trial
Evidence
low
Sample
N=32
Participants
32 women aged 20-45 years (average age 28.5) using a multi-peptide eye serum for periocular skincare

What This Study Found

A topical eye serum containing multiple bioactive peptides significantly reduced wrinkles around the eyes after 28 days of daily use in 32 women aged 20-45. The study documented decreases in wrinkle number, depth, and volume in the crow's feet area, along with improvements in skin hydration, elasticity, and firmness that increased continuously throughout the study period. 75% of participants expressed overall satisfaction with their skin appearance after using the product, and no adverse reactions were reported.

Key Numbers

n=32, average age 28.5 years, 28 days of use, 75% overall satisfaction

How They Did This

Thirty-two female subjects (average age 28.5) applied the multi-peptide eye serum daily for 28 days. Researchers measured skin hydration with a Corneometer CM825, skin elasticity with a Skin Elastometer MPA580, and wrinkle parameters (number, depth, volume) around the crow's feet area using PRIMOS CR digital strip projection imaging. Self-assessment questionnaires were completed on Days 14 and 28.

Why This Research Matters

Cosmetic peptides are one of the fastest-growing segments of the skincare industry, but clinical data supporting their efficacy has often lagged behind marketing claims. This study provides objective instrumental measurements — not just subjective reports — showing that a multi-peptide formulation can measurably improve wrinkle parameters and skin quality metrics around the eye area over a 28-day period.

The Bigger Picture

Peptide-based skincare has become a major category in cosmetic dermatology, with peptides like palmitoyl pentapeptide (Matrixyl) and copper peptides leading the way. However, many products reach the market with limited clinical evidence. Studies like this one — using objective instruments rather than just consumer surveys — help bridge the gap between laboratory promise and real-world performance, even if the evidence level remains preliminary without placebo controls.

What This Study Doesn't Tell Us

This was a small, open-label study with no placebo or control group, making it impossible to distinguish the peptide effects from the moisturizing effects of the serum base. The sample size of 32 was modest, and the average participant age of 28.5 is young for an anti-aging study, where wrinkles are typically less pronounced. The 28-day duration is relatively short. The specific peptides in the formulation are not named in the abstract.

Questions This Raises

  • ?How much of the wrinkle reduction is due to the peptides specifically versus the moisturizing and hydrating properties of the serum base?
  • ?Would the results hold up in a placebo-controlled trial with older participants who have more pronounced wrinkles?
  • ?Which specific peptides were included in the formulation, and what are their individual mechanisms of action?

Trust & Context

Key Stat:
75% satisfaction rate Three-quarters of participants reported overall satisfaction with their skin appearance after 28 days of using the multi-peptide eye serum, with instrumental measurements confirming reductions in wrinkle parameters.
Evidence Grade:
This is a small, open-label clinical study with no control group. While it used objective instrumental measurements (a strength), the lack of a placebo comparator, modest sample size, and short duration limit the conclusions that can be drawn about the peptides' specific efficacy.
Study Age:
Published in 2023, this is a recent study reflecting current cosmetic peptide formulation technology. The methods and instruments used are standard in cosmetic dermatology research.
Original Title:
Clinical evidence of the efficacy and safety of a new multi-peptide anti-aging topical eye serum.
Published In:
Journal of cosmetic dermatology, 22(12), 3340-3346 (2023)
Database ID:
RPEP-07094

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can peptide eye serums really reduce wrinkles?

This study found measurable reductions in wrinkle number, depth, and volume after 28 days using a multi-peptide eye serum. However, without a placebo group, it's unclear how much of the improvement came from the peptides versus the moisturizing effects of the serum itself.

Were there any side effects from the peptide eye serum?

No adverse reactions were reported during the 28-day study. All participants noted good tolerability, and most confirmed the product's ease of application and texture.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07094·https://rethinkpeptides.com/research/RPEP-07094

APA

Li, Fengzhu; Chen, Haowei; Chen, Dongxiao; Zhang, Bingjie; Shi, Qingying; He, Xihong; Zhao, Huabing; Wang, Fang. (2023). Clinical evidence of the efficacy and safety of a new multi-peptide anti-aging topical eye serum.. Journal of cosmetic dermatology, 22(12), 3340-3346. https://doi.org/10.1111/jocd.15849

MLA

Li, Fengzhu, et al. "Clinical evidence of the efficacy and safety of a new multi-peptide anti-aging topical eye serum.." Journal of cosmetic dermatology, 2023. https://doi.org/10.1111/jocd.15849

RethinkPeptides

RethinkPeptides Research Database. "Clinical evidence of the efficacy and safety of a new multi-..." RPEP-07094. Retrieved from https://rethinkpeptides.com/research/li-2023-clinical-evidence-of-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.